For example, the incidence of CNS metastasis was found to be twice as high in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer compared with HER2-negative breast cancer (21.8% vs 11.1%, respectively)1. This evidence concerns the gene ERBB2 and breast carcinoma.